Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of parkinson’s disease

REFERENCES

• Alamed J, Wilcock DM, Diamond DM, et al. (2006). Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protocols, 1, 1671–9
   PubMed Web of Science ®Google Scholar
• Alvarez-Fischer D, Guerreiro S, Hunot S, et al. (2008). Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem, 107, 701–11
   PubMedGoogle Scholar
• Baier PC, Branisa P, Koch R, et al. (2006). Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats. Exp Brain Res, 169, 283–8
   PubMedGoogle Scholar
• Barraud Q, Lambrecq V, Forni C, et al. (2009). Sleep disorders in Parkinson’s disease: the contribution of the MPTP non-human primate model. Exp Neurol, 2, 574–82
   Google Scholar
• Beal MF. (2001). Experimental models of Parkinson’s disease. Nature, 2, 325–32
   Google Scholar
• Beal MF. (2010). Parkinson’s disease: a model dilemma. Nature, 466, S8–10
   Google Scholar
• Ben V, Bruguerolle B. (2000). Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci, 67, 1549–58
   PubMed Web of Science ®Google Scholar
• Bezard E, Dovero S, Bioulac B, Gross CE. (1997). Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neurosci Lett, 234, 47–50
   PubMedGoogle Scholar
• Bezard E, Dovero S, Imbert C, et al. (2000a). Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse, 38, 363–8
   PubMed Web of Science ®Google Scholar
• Bezard E, Jaber M, Gonon F, et al. (2000b). Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. Eur J Neurosci, 12, 2892–900
   PubMed Web of Science ®Google Scholar
• Borbély AA, Achermann P. (1999). Sleep homeostasis and models of sleep regulation. J Biol Rhythms, 14, 557–68
   PubMed Web of Science ®Google Scholar
• Bosboom JL, Stoffers D, Wolters ECH. (2004). Cognitive dysfunction and dementia in Parkinson’s disease. J Neural Transm, 111, 1303–15
   PubMed Web of Science ®Google Scholar
• Bubser M, Schmidt WJ. (1990). 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res, 37, 157–68
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Schapira AH. (2009). Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol, 8, 464–74
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Healy DG, Schapira AH. (2006). Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol, 5, 235–45
   PubMed Web of Science ®Google Scholar
• Chesselet MF, Richter F. (2011). Modelling of Parkinson's disease in mice. Lancet Neurol, 10, 1108–18
   PubMed Web of Science ®Google Scholar
• Cleren C, Yang L, Lorenzo B, et al. (2008). Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem, 104, 1613–21
   PubMed Web of Science ®Google Scholar
• Collier TJ, Kanaan NM, Kordower JH. (2011). Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci, 12, 359–66
   PubMed Web of Science ®Google Scholar
• Da Cunha C, Angelucci ME, Canteras NS, et al. (2002). The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson’s disease memory disabilities. Cell Mol Neurobiol, 22, 227–37
   PubMed Web of Science ®Google Scholar
• Dawson TM, Ko HS, Dawson VL. (2010). Genetic animal models of Parkinson’s disease. Neuron, 66, 646–61
   PubMed Web of Science ®Google Scholar
• De Cock VC, Vidailhet M, Arnulf I. (2008). Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol, 4, 254–66
   PubMedGoogle Scholar
• Deguil J, Chavant F, Lafay-Chebassier C, et al. (2010). Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox Res, 17, 142–55
   PubMed Web of Science ®Google Scholar
• Dijk DJ, Lockley SW. (2002). Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol, 92, 852–62
   PubMed Web of Science ®Google Scholar
• Dkhissi-Benyahya O, Sicard B, Cooper HM. (2000). Effects of irradiance and stimulus duration on early gene expression (Fos) in the suprachiasmatic nucleus: temporal summation and reciprocity. J Neurosci, 20, 7790–7
   PubMed Web of Science ®Google Scholar
• Dluzen DE, Kreutzberg JD. (1993). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse. Brain Res, 609, 98–102
   PubMedGoogle Scholar
• Doi M, Yujnovsky I, Hirayama J, et al. (2006). Impaired light masking in dopamine D2 receptor-null mice. Nat Neurosci, 9, 732–4
   PubMed Web of Science ®Google Scholar
• Fleming SM, Salcedo J, Hutson CB, et al. (2008). Impaired reversal learning in transgenic mice overexpressing human wildtype alpha-synuclein. Soc. Neurosci. Abstract 341.1, N3
   Google Scholar
• Fornai F, Schlüter OM, Lenzi P, et al. (2005). Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A, 102, 3413–8
   PubMed Web of Science ®Google Scholar
• Fox SH, Brotchie JM. (2010). The MPTP-lesioned non-human primate models of Parkinson’s disease: past, present, and future. Prog Brain Res, 184, 133–57
   PubMedGoogle Scholar
• Fujita K, Seike T, Yutsudo N, et al. (2009). Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. PLoS ONE, 4, e7247
   PubMed Web of Science ®Google Scholar
• Gibrat C, Saint-Pierre M, Bousquet M, et al. (2009). Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem, 109, 1469–82
   PubMed Web of Science ®Google Scholar
• Gravotta L, Gavrila AM, Hood S, Amir S. (2011). Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. J Mol Neurosci, 45, 162–71
   PubMedGoogle Scholar
• Hood S, Cassidy P, Cossette MP, et al. (2010). Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci, 30, 14046–58
   PubMed Web of Science ®Google Scholar
• Imbesi M, Yildiz S, Dirim Arslan A, et al. (2009). Dopamine receptor mediated regulation of neuronal “clock” gene expression. Neuroscience, 158, 537–44
   PubMed Web of Science ®Google Scholar
• Ishida Y, Yokoyama C, Inatomi T, et al. (2002). Circadian rhythm of aromatic L-amino acid decarboxylase in the rat suprachiasmatic nucleus: gene expression and decarboxylating activity in clock oscillating cells. Genes Cells, 7, 447–59
   PubMed Web of Science ®Google Scholar
• Jackson-Lewis V, Przedborski S. (2007). Protocol for the MPTP mouse model of Parkinson’s disease. Nat Protocols, 2, 141–51
   PubMed Web of Science ®Google Scholar
• Jackson-Lewis V, Przedborski S. (2008). The MPTP mouse model of Parkinson’s disease: the true, the false and the unknown. In Nass R, Przedborski S. (eds.). Parkinson’s disease: molecular and therapeutic insights from model systems. Amsterdam: Elsevier, pp. 147–58
   Google Scholar
• Johnson CH, Elliott JA, Foster R. (2003). Entrainment of circadian programs. Chronobiol Int, 20, 741–74
   PubMed Web of Science ®Google Scholar
• Kudo T, Loh DH, Truong D, et al. (2011). Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol, 232, 66–75
   PubMed Web of Science ®Google Scholar
• Laloux C, Derambure P, Kreisler A, et al. (2008). MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations. Exp Brain Res, 186, 635–42
   PubMedGoogle Scholar
• Lax P, Esquiva G, Esteve-Rudd J, et al. (2012). Circadian dysfunction in a rotenone-induced parkinsonian rodent model. Chronobiol Int, 29, 147–56
   PubMed Web of Science ®Google Scholar
• Lima MM, Andersen ML, Reksidler AB, et al. (2007). The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS ONE, 6, e513
   Google Scholar
• Maetzler W, Liepelt I, Berg D. (2009). Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol, 8, 1158–71
   PubMed Web of Science ®Google Scholar
• Magen I, Chesselet MF. (2010). Genetic mouse models of Parkinson’s disease: the state of the art. Prog Brain Res, 184, 53–87
   PubMedGoogle Scholar
• Mrosovsky N. (1999). Masking: history, definitions, and measurement. Chronobiol Int, 4, 415–29
   Google Scholar
• Pfeffer M, Plenzig S, Gispert S, et al. (2012). Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene. Neurobiol Aging, 33, 393–403
   PubMedGoogle Scholar
• Pham TT, Giesert F, Röthig A, et al. (2010). DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments. Genes Brain Behav, 9, 305–17
   PubMedGoogle Scholar
• Pifl C, Hornykiewicz O. (2006). Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem Int, 49, 519–24
   PubMedGoogle Scholar
• Plowman EK, Kleim JA. (2011). Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson’s disease. J Commun Disord, 44, 549–56
   PubMedGoogle Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int, 27, 1911–29
   PubMed Web of Science ®Google Scholar
• Potashkin JA, Blume SR, Runkle NK. (2011). Limitations of animal models of Parkinson’s disease. Parkinsons Dis. 2011:658083
   Google Scholar
• Pothakos K, Kurz MJ, Lau YS. (2009). Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson’s disease with severe neurodegeneration. BMC Neurosci, 10, 6
   PubMedGoogle Scholar
• Przedborski S, Vila M. (2003). The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson’s disease. Ann N Y Acad Sci, 991, 189–98
   PubMed Web of Science ®Google Scholar
• Redlin U. (2001). Neural basis and biological function of masking by light in mammals: suppression of melatonin and locomotor activity. Chronobiol Int, 5, 737–58
   Google Scholar
• Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature, 418, 935–41
   PubMed Web of Science ®Google Scholar
• Rieux C, Carney R, Lupi D, et al. (2002). Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. J Biol Rhythms, 17, 121–36
   PubMed Web of Science ®Google Scholar
• Rye D. (2010). Seeing beyond one’s nose: sleep disruption and excessive sleepiness accompany motor disability in the MPTP treated primate. Exp Neurol, 2, 179–80
   Google Scholar
• Schapira AH, Jenner P. (2011). Etiology and pathogenesis of Parkinson’s disease. Mov Disord, 26, 1049–55
   PubMed Web of Science ®Google Scholar
• Schneider JS, Pope-Coleman A. (1995). Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration, 4, 245–55
   PubMedGoogle Scholar
• Sedelis M, Schwarting RK, Huston JP. (2001). Behavioral phenotyping of the MPTP mouse model of Parkinson’s disease. Behav Brain Res, 125, 109–25
   PubMed Web of Science ®Google Scholar
• Simon H, Taghzouti K, Le Moal M. (1986). Deficits in spatial-memory tasks following lesions of septal dopaminergic terminals in the rat. Behav Brain Res, 19, 7–16
   PubMedGoogle Scholar
• Sokolove PG, Bushell WN. (1978). The chi square periodogram: its utility for analysis of circadian rhythms. J Theor Biol, 72, 131–60
   PubMed Web of Science ®Google Scholar
• Stam CJ, de Bruin JP, van Haelst AM, et al. (1989). Influence of the mesocortical dopaminergic system on activity, food hoarding, social-agonistic behavior, and spatial delayed alternation in male rats. Behav Neurosci, 103, 24–35
   PubMedGoogle Scholar
• Tanila H, Björklund M, Riekkinen P Jr. (1998). Cognitive changes in mice following moderate MPTP exposure. Brain Res Bull, 45, 577–82
   PubMedGoogle Scholar
• Taylor TN, Greene JG, Miller GW. (2010). Behavioral phenotyping of mouse models of Parkinson’s disease. Behav Brain Res, 211, 1–10
   PubMed Web of Science ®Google Scholar
• Thomas B, von Coelln R, Mandir AS, et al. (2007). MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis, 26, 312–22
   PubMedGoogle Scholar
• Valentinuzzi VS, Scarbrough K, Takahashi JS, Turek FW. (1997). Effects of aging on the circadian rhythm of wheel-running activity in C57BL/6 mice. Am J Physiol, 273, R1957–64
   PubMed Web of Science ®Google Scholar
• Vezoli J, Fifel K, Leviel V, et al. (2011). Early presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson’s disease. PLoS ONE, 6, e23952
   Google Scholar
• Videnovic A, Golombek D. (2013). Circadian and sleep disorders in Parkinson's disease. Exp Neurol, 243, 45--56
   Google Scholar
• Viyoch J, Matsunaga N, Yoshida M, et al. (2005). Effect of haloperidol on mPer1 gene expression in mouse suprachiasmatic nuclei. J Biol Chem, 280, 6309–15
   PubMedGoogle Scholar
• Vorhees CV, Williams MT. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protocols, 1, 848–58
   PubMed Web of Science ®Google Scholar
• Weaver DR, Rivkees SA, Reppert SM. (1992). D1-dopamine receptors activate c-fos expression in the fetal suprachiasmatic nuclei. Proc Natl Acad Sci U. S. A, 89, 9201–4
   PubMedGoogle Scholar
• Yang J, He L, Wang J, Adams JD Jr. (2004). Early administration of nicotinamide prevents learning and memory impairment in mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Pharmacol Biochem Behav, 78, 179–83
   PubMed Web of Science ®Google Scholar
• Yang L, Calingasan NY, Thomas B, et al. (2009a). Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS ONE, 4, e5757
   PubMed Web of Science ®Google Scholar
• Yang L, Calingasan NY, Wille EJ, et al. (2009b). Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s diseases. J Neurochem, 109, 1427–39
   PubMed Web of Science ®Google Scholar
• Zhu XR, Maskri L, Herold C, et al. (2007). Non-motor behavioural impairments in parkin-deficient mice. Eur J Neurosci, 26, 1902–11
   PubMedGoogle Scholar